Human Heart-Type Cytoplasmic Fatty Acid-Binding Protein (H-FABP) for the Diagnosis of Acute Myocardial Infarction. Clinical Evaluation of H-FABP in Comparison with Myoglobin and Creatine Kinase Isoenzyme MB-Reference-Cited by-同舟云学术

Human Heart-Type Cytoplasmic Fatty Acid-Binding Protein (H-FABP) for the Diagnosis of Acute Myocardial Infarction. Clinical Evaluation of H-FABP in Comparison with Myoglobin and Creatine Kinase Isoenzyme MB

Published:2000-01-25 Issue:3 Volume:38 Page:
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine
language:
Short-container-title:

Author:

Okamoto Fumio,Sohmiya Koichi,Ohkaru Yasuhiko,Kawamura Keishiro,Asayama Kumiko,Kimura Hiroshi,Nishimura Shinzo,Ishii Hiroo,Sunahara Noriyuki,Tanaka Takao

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/CCLM.2000.034/pdf

Reference31 articles.

1. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.

2. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity

3. Acute myocardial infarction and MB creatine phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme

4. Several Conditions Causing Elevation of Serum CK-MB and CK-BB

5. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of H-FABP with cardiovascular events: A systematic review;J CARDIOVASC THORAC;2024

2. Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction;Scientific Reports;2024-02-10

3. Circulating biomarkers in the setting of stress test-induced myocardial ischemia – a review of potential candidates for introduction into clinical practice;Medical Studies;2024

4. Dose Range Finding (DRF) Studies in Drug Toxicology Assessments;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

5. Advances in congestive heart failure biomarkers;Advances in Clinical Chemistry;2023